ArticlePLOS global public health2026
Governing antibiotic resistance through One Health: Insights from the political and legal landscape in Senegal.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR), especially antibiotic resistance (ABR), could cause up to 10 million deaths per year by 2050. While ABR is a natural phenomenon, it is exacerbated by antibiotic misuse, poor sanitation, insufficient health infrastructure, weak biosecurity, and environmental contamination. The cross-transmission of resistant bacteria between humans, animal and the environment requires a multi-sectoral response inspired by the One Health concept. With the support of international partners and in line with global policies, Senegal has established a national One Health platform and legal measures to combat ABR. Our study proposes to examine the One Health governance capacities for managing ABR in Senegal, and to identify ways of improvement from a One Health perspective. A qualitative approach was adopted, combining the review of 64 legal instruments and 26 semi-structured interviews conducted between January and August 2023 with actors from governmental, private and non-governmental institutions. The analysis focused on governance structure, legal instrument development and implementation, and ABR surveillance programmes. The thematic analysis of the interview contents highlighted factors influencing the One Health governance capacities in Senegal. One Health governance has been institutionalized in Senegal since 2017 with the creation of the national One Health platform housed at the Prime Minister's Office. However, its effectiveness is limited by weak formalization, inadequate resources, and reliance on external funding. Outdated and poorly enforced legal frameworks hinder ABR management, while rural areas lack sufficient laboratory infrastructure, leading to inappropriate antibiotic use and weak surveillance systems. Power imbalances among stakeholders impede collective action and data-sharing. Despite progress toward international standards, systemic barriers persist. Strengthening the legal framework, improving healthcare infrastructure, and enhancing the One Health platform's status and funding are critical. Institutionalization must connect global orientations with local realities to avoid inequities. Sustainable ABR management requires inclusive, context-sensitive policies, robust domestic investment, and equitable collaboration among stakeholders across the sectors of human, animal, and environmental health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.